Welcome to our dedicated page for CHNG news (Ticker: CHNG), a resource for investors and traders seeking the latest updates and insights on CHNG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CHNG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CHNG's position in the market.
The U.S. District Court for the District of Columbia has denied the U.S. Department of Justice's request to block the merger between UnitedHealth Group (NYSE: UNH) and Change Healthcare (NASDAQ: CHNG). The merger will combine Change Healthcare with Optum Insight. Following this, Change Healthcare will issue a special dividend of $2.00 per share to stockholders of record prior to the merger's effective time. The dividend is to be paid shortly after the merger closes, contingent on closing conditions.
Change Healthcare (Nasdaq: CHNG) reported total revenue of $884.5 million for Q1 FY2023, up from $867.9 million in Q1 FY2022. Solutions revenue grew 1.8% to $831.3 million, driven by increased sales. However, net loss was $(23.2) million, compared to a loss of $(3.6) million a year prior. Adjusted EBITDA declined by 0.9% to $280.2 million. The company also announced no financial guidance due to the pending merger with OptumInsight and will pay a one-time special dividend of up to $2.00 per share upon completion of the merger.
Change Healthcare (Nasdaq: CHNG) will release its first quarter fiscal 2023 financial results after market close on August 3, 2022. A conference call is scheduled for August 4, 2022, at 8:00 am ET, where no questions will be taken due to an ongoing transaction with OptumInsight. Investors can listen live at Change Healthcare's website, with a recording available until August 4, 2023.
Change Healthcare (NASDAQ: CHNG) launched a new Patient Engagement suite that merges its revenue cycle management solutions with Luma Health’s Patient Success Platform. This integrated approach enhances communication and accessibility for patients, potentially increasing appointment-based revenue by 47%. With patients seeking convenience, the suite aims to reduce administrative burdens and patient wait times, which can average 24 days. By improving patient autonomy and satisfaction, Change Healthcare aims to streamline the healthcare journey and improve financial outcomes for providers.
Change Healthcare reported strong financial results for Q4 2022, achieving $920 million in total revenue, an increase from $855.2 million in Q4 2021. Solutions revenue rose by 6.8% to $859.2 million, driven by increased volume and COVID-19 activities. The company posted a net income of $7.1 million, compared to a loss of $13.1 million in the previous year. Adjusted EBITDA grew by 3.8% to $282.3 million. Cash flow from operations reached $696.9 million, with free cash flow at $420.6 million, a 23.8% increase from fiscal 2021.
Change Healthcare Inc. (Nasdaq: CHNG) will announce its fourth quarter and full year fiscal 2022 financial results after market close on May 25, 2022. A conference call is scheduled for May 26, 2022, at 8:00 am ET. Notably, due to the transaction with OptumInsight, the company will not take questions during the call. Investors can access the call via the company's website, with on-demand listening available until May 26, 2023. Change Healthcare focuses on healthcare technology solutions to enhance clinical and administrative outcomes in the U.S. healthcare system.
Change Healthcare (NASDAQ: CHNG) announced the release of InterQual 2022, enhancing clinical decision support. The update introduces new criteria, AI-driven insights, and streamlined workflows. New modules include guidelines from the American College of Cardiology and American Heart Association. The release aims to improve efficiency in utilization management and patient care outcomes, leveraging advanced analytics and automation.
Optum and Change Healthcare have extended their merger agreement until December 31, 2022, amid a legal challenge from the U.S. Department of Justice. The companies express confidence in the merger's potential to enhance healthcare by reducing costs and improving stakeholder experiences. A $650 million fee is set if the merger fails due to court decisions, while shareholders of Change Healthcare will receive a special cash dividend of $2.00 per share at closing. A trial is scheduled to begin on August 1 to address the merger's challenges.
Change Healthcare (NASDAQ: CHNG) expressed disappointment over the DOJ's decision to pursue litigation to block its proposed merger with UnitedHealth Group. As previously disclosed, the merger agreement has been extended until April 5, 2022. The company aims to continue supporting UHG in efforts to close the merger while fulfilling its obligations under the agreement. Change Healthcare focuses on enhancing the U.S. healthcare system through data-driven solutions that improve clinical and operational outcomes.
Change Healthcare (NASDAQ: CHNG) has received the 2022 Best in KLAS award for Payer IT Consulting Services, marking its third recognition in four years. This award is based on feedback from over 22,000 healthcare providers and payers, highlighting the company’s commitment to quality and customer service. Change Healthcare's Consulting Services helps payers enhance business performance through various solutions, including analytics and IT risk management. Executive VP Thomas Laur emphasized their dedication to exceptional customer service and healthcare improvement.
FAQ
What is the market cap of CHNG (CHNG)?
